ABBV
AbbVie IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$402.35B
P/E Ratio
111.09
EPS
$2.05
Beta
0.31
52W High
$239.13
52W Low
$176.00
50-Day MA
$210.80
200-Day MA
$220.35
Dividend Yield
3.00%
Profit Margin
5.79%
Forward P/E
15.97
PEG Ratio
0.63
About AbbVie Inc
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Fundamentals
| Revenue (TTM) | $62.82B |
| Gross Profit (TTM) | $45.25B |
| EBITDA | $29.92B |
| Operating Margin | 32.20% |
| Return on Equity | 62.30% |
| Return on Assets | 10.00% |
| Revenue/Share (TTM) | $35.50 |
| Book Value | $-3.77 |
| Price-to-Book | 50.46 |
| Price-to-Sales (TTM) | 6.40 |
| EV/Revenue | 7.42 |
| EV/EBITDA | 27.53 |
| Quarterly Earnings Growth (YoY) | -46.20% |
| Quarterly Revenue Growth (YoY) | 12.40% |
| Shares Outstanding | $1.77B |
| Float | $1.76B |
| % Insiders | 0.11% |
| % Institutions | 76.89% |
Historical Volatility
HV 10-Day
26.29%
HV 20-Day
21.55%
HV 30-Day
21.35%
HV 60-Day
23.30%
HV Rank
21.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($253.55 target)
8
Strong Buy16
Buy8
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026